tiprankstipranks
Biesse SPA (IT:BSS)
:BSS
Want to see IT:BSS full AI Analyst Report?

Biesse SPA (BSS) AI Stock Analysis

10 Followers

Top Page

IT:BSS

Biesse SPA

(BSS)

Select Model
Select Model
Select Model
Neutral 44 (OpenAI - 5.2)
Rating:44Neutral
Price Target:
€5.00
▼(-1.38% Downside)
Action:Reiterated
Date:06/17/26
The score is weighed down primarily by deteriorating financial performance (declining revenue, sharp margin compression, and a recent net loss) alongside higher leverage and unstable/free cash flow. Technicals add mild pressure (negative MACD and below the 200-day average), while valuation remains constrained by loss-making earnings and the lack of a dividend yield.
Positive Factors
Diversified product & market exposure
Serving multiple materials and end markets (wood, glass, stone, advanced composites) provides durable revenue diversification. This reduces reliance on any single cyclical sector, supports cross‑selling of machines and systems, and helps stabilize demand over multiquarter periods.
Negative Factors
Declining revenue and margins
Multi‑year revenue declines and sharp margin compression culminating in a net loss in 2025 are structurally concerning. Sustained top‑line weakness and lower gross margins reduce internal funds for R&D, capex and service expansion, weakening competitive positioning over time.
Read all positive and negative factors
Positive Factors
Negative Factors
Diversified product & market exposure
Serving multiple materials and end markets (wood, glass, stone, advanced composites) provides durable revenue diversification. This reduces reliance on any single cyclical sector, supports cross‑selling of machines and systems, and helps stabilize demand over multiquarter periods.
Read all positive factors

Biesse SPA (BSS) vs. iShares MSCI Italy ETF (EWI)

Biesse SPA Business Overview & Revenue Model

Company Description
Biesse S.p.A. specializes in developing, producing, and supplying advanced machinery, comprehensive integrated systems, and specialized software solutions. These offerings primarily cater to manufacturers in the furniture, fenestration (windows an...
How the Company Makes Money
Biesse makes money primarily by selling capital equipment (industrial machines and integrated production systems) to manufacturers that process wood, glass, stone, and other materials. A significant portion of revenue typically comes from (1) new ...

Biesse SPA Financial Statement Overview

Summary
Overall financial performance is weak: revenues have declined for multiple years, margins compressed sharply, and 2025 shows a net loss. Leverage has increased meaningfully (reducing flexibility) and free cash flow has been volatile and recently very low, partially offset by continued positive operating cash flow and a still-meaningful equity cushion.
Income Statement
38
Negative
Balance Sheet
54
Neutral
Cash Flow
46
Neutral
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue814.28M662.48M754.70M785.00M822.42M742.20M
Gross Profit350.00M71.14M419.45M449.38M451.34M396.46M
EBITDA19.20M23.59M50.41M53.78M73.93M73.41M
Net Income-24.82M-19.57M3.75M12.48M30.25M34.02M
Balance Sheet
Total Assets678.07M702.34M818.22M649.80M727.13M722.77M
Cash, Cash Equivalents and Short-Term Investments127.90M131.75M203.75M104.87M145.58M154.20M
Total Debt163.42M156.40M207.03M28.13M26.34M27.54M
Total Liabilities459.49M475.99M554.85M388.36M466.34M473.56M
Stockholders Equity218.58M226.35M263.37M261.45M260.55M248.37M
Cash Flow
Free Cash Flow1.24M1.24M-5.21M4.06M20.09M89.72M
Operating Cash Flow20.41M20.41M14.30M16.14M39.65M103.88M
Investing Cash Flow-62.62M-62.62M-76.14M-14.78M-11.05M-8.35M
Financing Cash Flow-65.07M-65.07M137.64M-19.63M-30.23M-132.65M

Biesse SPA Technical Analysis

Technical Analysis Sentiment
Negative
Last Price5.07
Price Trends
50DMA
5.44
Negative
100DMA
5.56
Negative
200DMA
6.00
Negative
Market Momentum
MACD
-0.13
Positive
RSI
35.37
Neutral
STOCH
21.27
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IT:BSS, the sentiment is Negative. The current price of 5.07 is below the 20-day moving average (MA) of 5.16, below the 50-day MA of 5.44, and below the 200-day MA of 6.00, indicating a bearish trend. The MACD of -0.13 indicates Positive momentum. The RSI at 35.37 is Neutral, neither overbought nor oversold. The STOCH value of 21.27 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IT:BSS.

Biesse SPA Peers Comparison

Overall Rating
UnderperformOutperform
Sector (55)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
55
Neutral
$6.65B3.83-15.92%6.20%10.91%7.18%
44
Neutral
€137.29M-5.41-10.66%-12.22%-631.07%
43
Neutral
€10.99M-0.3417.04%74.59%
* General Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IT:BSS
Biesse SPA
5.07
-2.02
-28.49%
IT:FDA
Fidia Spa
0.01
-0.29
-96.70%
IT:ESAU
Esautomotion SpA
3.42
0.02
0.59%

Biesse SPA Corporate Events

Biesse Boosts Profitability Amid Weak Demand With Digital Push and Cost Discipline
Jul 31, 2026
Biesse reported first-half 2026 results in a challenging macroeconomic and geopolitical environment, with ongoing pressure on volumes and margins across its core markets. The group is maintaining a cautious stance on costs, investments and liquidi...
Biesse boosts long‑term shareholder influence with enhanced voting rights
Jun 4, 2026
Biesse S.p.A. has activated a strengthened increased voting right on 13,970,500 of its ordinary shares as of 2 May 2026, resulting in three votes per share for this tranche. Following the change, the company’s total share capital remains at ...
Biesse Names Stefano Porcellini Deputy CEO and Incoming CFO After Board Reshuffle
May 5, 2026
Biesse’s board has co‑opted Stefano Porcellini as a new director following the resignation of Alessandra Baronciani, and will submit his appointment to the next shareholders’ meeting for approval. The board has confirmed that he ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jun 17, 2026